{"id":259085,"date":"2010-02-01T09:15:27","date_gmt":"2010-02-01T14:15:27","guid":{"rendered":"http:\/\/www.xconomy.com\/?p=61155"},"modified":"2010-02-01T09:15:27","modified_gmt":"2010-02-01T14:15:27","slug":"boston-scientific-to-pay-johnson-johnson-1-7-billion-in-stent-settlements","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/259085","title":{"rendered":"Boston Scientific to Pay Johnson &amp; Johnson $1.7 Billion in Stent Settlements"},"content":{"rendered":"\n<div style=\"text-transform:uppercase\"><a href=\"http:\/\/www.xconomy.com\/tag\/healthcare\/\">healthcare<\/a>, <a href=\"http:\/\/www.xconomy.com\/tag\/Legal\/\">Legal<\/a>, <a href=\"http:\/\/www.xconomy.com\/tag\/Life-Sciences\/\">Life Sciences<\/a><\/div>\n<p>\t\t<a rel=\"attachment wp-att-61156\" href=\"http:\/\/www.xconomy.com\/?attachment_id=61156\"><img loading=\"lazy\" decoding=\"async\" style=\"float:right;margin: 0px 0 5px 15px;\" class=\"alignnone size-full wp-image-61156\" title=\"Boston Scientific Logo\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/images\/2010\/02\/bsx-logo1.png\" alt=\"Boston Scientific Logo\" width=\"163\" height=\"66\" \/><\/a><br \/>\n\t\t<strong>Wade Roush wrote:<\/strong><\/p>\n<p>Pushing to get past a raft of pending patent infringement lawsuits, Boston Scientific (NYSE: <a href=\"http:\/\/finance.yahoo.com\/q?s=BSX\">BSX<\/a>) <a href=\"http:\/\/bostonscientific.mediaroom.com\/index.php?s=43&amp;item=893\">said today<\/a> that it will pay Johnson &amp; Johnson $1.725 billion to settle three suits related to cardiac stent technology.<\/p>\n<p>The Natick, MA-based medical devices giant said it will pay Johnson &amp; Johnson $1 billion today, and the remaining $725 million within the next 11 months. The settlements mean Boston Scientific can sidestep risky jury trials in three separate cases involving claims by Johnson &amp; Johnson that three of its stent patents were infringed by a variety of Boston Scientific products, including its Express, Taxus Express, Liberte, Cypher, BX Velocity, Genesis, and Taxus Liberte stents.<\/p>\n<p>Last September, Boston Scientific announced a <a href=\"http:\/\/www.xconomy.com\/boston\/2009\/09\/29\/boston-scientific-pays-716m-to-settle-patent-dispute-with-jj\/\">$716 million settlement<\/a> that brought an end to 14 other patent lawsuits involving Johnson &amp; Johnson. President and CEO Ray Elliott said in a statement today that the settlements are all part of an effort to &#8220;mitigate risk&#8221; at Boston Scientific, including litigation risk.<\/p>\n<p>&#8220;In the past year, we have significantly reduced the volume of outstanding litigation, having now settled 17 lawsuits with J&amp;J, as well as disputes with other competitors and the government,&#8221; Elliott said. &#8220;We believe today&#8217;s settlement&#8212;while substantial&#8212;is in the best interest of the Company and its shareholders. It resolves major litigation without exposing Boston Scientific to the uncertainties of a jury trial and a potential damages award that was impossible to predict&#8230;With the resolution of these matters, there are now no material judgments or jury verdicts pending against the Company.&#8221;<\/p>\n<div class=\"postFooter\"><a href=\"http:\/\/www.xconomy.com\/boston\/2010\/02\/01\/boston-scientific-to-pay-johnson-johnson-1-7-billion-in-stent-settlements\/#comments\">Comments (1)<\/a> | <a href=http:\/\/www.xconomy.com\/reprints\/>Reprints<\/a> | Share: &nbsp;<br \/>\n<a href=\"http:\/\/twitter.com\/home?status=RT%20@Xconomy%20Boston%20Scientific%20to%20Pay%20Johnson%20&#038;%20Johnson%20$1.7%20Billion%20in%20Stent%20Settlements%20http:\/\/xconomy.com\/?p=61155\"  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/twitter.gif\" alt=\"Retweet\"\/><\/a><br \/>\n&nbsp;<a href=\"http:\/\/www.facebook.com\/sharer.php?u=http:\/\/www.xconomy.com\/boston\/2010\/02\/01\/boston-scientific-to-pay-johnson-johnson-1-7-billion-in-stent-settlements\/&#038;t=Boston%20Scientific%20to%20Pay%20Johnson%20&#038;%20Johnson%20$1.7%20Billion%20in%20Stent%20Settlements\"  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/facebook.gif\" alt=\"Facebook\"\/><\/a><br \/>\n&nbsp;<a href=http:\/\/www.xconomy.com\/boston\/2010\/02\/01\/boston-scientific-to-pay-johnson-johnson-1-7-billion-in-stent-settlements\/email\/  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/email.gif\" alt=\"Email\"\/><\/a><br \/>\n&nbsp;<a href=\"http:\/\/sharethis.com\/item?publisher=bfda184d-6684-4f7a-a23f-ca4ed4db9287&amp;title=Boston+Scientific+to+Pay+Johnson+%26%23038%3B+Johnson+%241.7+Billion+in+Stent+Settlements&amp;url=http%3A%2F%2Fwww.xconomy.com%2Fboston%2F2010%2F02%2F01%2Fboston-scientific-to-pay-johnson-johnson-1-7-billion-in-stent-settlements%2F\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/share.gif\" alt=\"Share\"\/><\/a>\n<\/div>\n<p>\t     \t\t<br clear=\"both\" style=\"clear: both;\"\/><br \/>\n<br clear=\"both\" style=\"clear: both;\"\/><br \/>\n<a href=\"http:\/\/ads.pheedo.com\/click.phdo?s=dcf20399db29b59190daa6f598caa32e&#038;p=1\"><img decoding=\"async\" alt=\"\" style=\"border: 0;\" border=\"0\" src=\"http:\/\/ads.pheedo.com\/img.phdo?s=dcf20399db29b59190daa6f598caa32e&#038;p=1\"\/><\/a><br \/>\n<img loading=\"lazy\" decoding=\"async\" alt=\"\" height=\"0\" width=\"0\" border=\"0\" style=\"display:none\" src=\"http:\/\/a.rfihub.com\/eus.gif?eui=2218\"\/><\/p>\n<p><a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/4I8KPkEJRkMg7DBIRmTA6euYgwI\/0\/da\"><img decoding=\"async\" src=\"http:\/\/feedads.g.doubleclick.net\/~a\/4I8KPkEJRkMg7DBIRmTA6euYgwI\/0\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><br \/>\n<a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/4I8KPkEJRkMg7DBIRmTA6euYgwI\/1\/da\"><img decoding=\"async\" src=\"http:\/\/feedads.g.doubleclick.net\/~a\/4I8KPkEJRkMg7DBIRmTA6euYgwI\/1\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~r\/Xconomy_Full\/~4\/xQUWvz6nSng\" height=\"1\" width=\"1\"\/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>healthcare, Legal, Life Sciences Wade Roush wrote: Pushing to get past a raft of pending patent infringement lawsuits, Boston Scientific (NYSE: BSX) said today that it will pay Johnson &amp; Johnson $1.725 billion to settle three suits related to cardiac stent technology. The Natick, MA-based medical devices giant said it will pay Johnson &amp; Johnson [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-259085","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/259085","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=259085"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/259085\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=259085"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=259085"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=259085"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}